LRPAP1 and glioblastoma: In our previous work, we encapsulated a receptor-associated protein (RAP) polymeric peptide and the ferroptosis inducer FIN56 on GDY to design a GDY-FIN56-RAP (GFR) nanoplatform with a PTT effect for GBM therapy.